MedTrace Logo

Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches

NCT00313105 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2009-09-15

No results posted yet for this study

Summary

To test if smokeless tobacco is more effective than nicotine buccal tablets in smoking cessation compared with a control group with low dose nicotine patches.

Also retreatment will be tested with smokeless tobacco every 6 months in failures for 1½ year. Adherence to the program will be enhanced by assessment of cholesterol, blood pressure, lung function and body weight every 6 months for 2 years.

Conditions

  • Tobacco Dependence

Interventions

DRUG

Smokeless tobacco (Oliver Twist pellets)

individual visits with counseling

BEHAVIORAL

smoking cessation counseling

individual visits

Sponsors & Collaborators

  • Danish Research Foundation, FSS, Copenhagen, Denmark

    collaborator UNKNOWN

  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Principal Investigators

  • Philip Tønnesen, M.D., Ph.D. · Chair dept. pulm. medicine, Gentofte Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2010-04-30
Completion
2010-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00313105 on ClinicalTrials.gov